Tatsuki Mizuochi

31PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersInfant and child healthAdolescent healthNeonatologyRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 14, 2026
Absence of progressive liver disease after treatment in children with chronic hepatitis C: A nationwide registry study.

|May 18, 2026
Efficacy and Safety of High-Dose Multimatrix Mesalazine in Pediatric Patients with Mild-to-Moderate Active Ulcerative Colitis.

|Apr 18, 2026
Safety and Effectiveness of Glecaprevir/Pibrentasvir in Children and Adolescents With Chronic Hepatitis C: Reports From All-Case Post-Marketing Surveillance in Japan.

|Aug 28, 2025
Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort study.

Hirotaka Shimizu, Ryusuke Nambu, Nao Tachibana

|Jul 21, 2025
Efficacy and Safety of Glecaprevir/Pibrentasvir in Children Aged 3-11 Years With Chronic Hepatitis C: A Real-World, Prospective, Multicenter Study in Japan.

Tatsuki Mizuochi, Daiki Abukawa, Ayano Inui

|May 21, 2025
Long-Term Response Durability of Infliximab for Pediatric Inflammatory Bowel Disease in Japan: A Single Center Experience.

Naoya Tsumura, Ken Kato, Ryosuke Yasuda

Pageof 6

Frequent Collaborators

6 joint publications

Katsuhiro Arai

6 joint publications

Takahiro Kudo

6 joint publications

Itaru Iwama

4 joint publications

Hitoshi Tajiri